Economic burden of systemic sclerosis: systematic review
Background. Systemic sclerosis (SSc) is a severe orphan disease, one of the systemic pathologies of connective tissue. This disease has a significant negative impact on the patient’s quality of life and has a high mortality rate. Treatment of its various complications imposes a great financial burde...
Saved in:
| Main Authors: | D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2020-11-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/422 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global economic burden of schizophrenia: a systematic review
by: Chong HY, et al.
Published: (2016-02-01) -
The economic burden of malaria in Africa: a systematic review of cost of illness studies
by: Anteneh Lamesgen, et al.
Published: (2025-07-01) -
Health loss and economic burden of asthma in China: a qualitative review based on existing literature
by: Peng Zhang, et al.
Published: (2025-02-01) -
Economic burden of hepatitis B patients and its influencing factors in China: a systematic review
by: Mengxia Yan, et al.
Published: (2024-11-01) -
Economic burden of pulmonary hypertension. Systematic review
by: V. D. Zakiev, et al.
Published: (2024-10-01)